Drug-drug interaction between ticagrelor and fazamorexant: pharmacokinetic alterations in healthy subjects from a phase I, open-label, fixed-sequence study.
- DOI
- 10.1186/s40360-026-01186-0
- Published
- 2026 Jul 22
- Container
- BMC pharmacology & toxicology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40360-026-01186-0,
title = {Drug-drug interaction between ticagrelor and fazamorexant: pharmacokinetic alterations in healthy subjects from a phase I, open-label, fixed-sequence study.},
author = {Huang X and Chen Y and Jin L and Kong Y and Bao F and Wang R},
year = {2026},
journal = {BMC pharmacology \& toxicology},
doi = {10.1186/s40360-026-01186-0},
url = {https://doi.org/10.1186/s40360-026-01186-0}
}RIS
TY - JOUR TI - Drug-drug interaction between ticagrelor and fazamorexant: pharmacokinetic alterations in healthy subjects from a phase I, open-label, fixed-sequence study. AU - Huang X AU - Chen Y AU - Jin L AU - Kong Y AU - Bao F AU - Wang R PY - 2026 JO - BMC pharmacology & toxicology DO - 10.1186/s40360-026-01186-0 UR - https://doi.org/10.1186/s40360-026-01186-0 ER -
APA
X, H., Y, C., L, J., Y, K., F, B., & R, W. (2026). Drug-drug interaction between ticagrelor and fazamorexant: pharmacokinetic alterations in healthy subjects from a phase I, open-label, fixed-sequence study.. BMC pharmacology & toxicology. https://doi.org/10.1186/s40360-026-01186-0
Source records
- pubmed · retrieved 2026-09-27T12:08:30.913Z